Sayin, MVarol, FGSayin, NC2024-06-122024-06-1220050301-21151872-7654https://doi.org/10.1016/j.ejogrb.2005.03.020https://hdl.handle.net/20.500.14551/2330319th European Congress of Perinatal Medicine -- OCT 14-16, 2004 -- Athens, GREECEObjective: To evaluate the role of natural coagulation inhibitors in various classifications of pregnancy associated hypertension in Turkish population living in Trakya region of Turkey. Study design: Serum uric acid levels, plasma protein C (PC), protein S (PS), antithrombin III (AT 111) activities and activated protein C resistance (APCR) were measured in 80 pregnant women with hypertension (preeclampsia, n = 32; severe preeclampsia, n = 25; eclampsia, n = 14; chronic hypertension, n = 9) and 58 healthy pregnant women. Tukey and Tamhane multiple comparison tests, Kruskal-Wallis, X 2 and Fisher's exact tests were performed for comparison of means and/or medians. Results: Serum uric acid levels were significantly elevated in women with preeclampsia and severe preeclampsia, but PS activity decreased in women with severe preeclampsia (33.2 +/- 18.9% versus 50.4 +/- 22.7%, p = 0.015) and chronic hypertension (29.5 +/- 14.5% versus 50.4 22.7%, p = 0.045) compared to healthy controls. There was no significant difference in APCR, and PC or AT III activity between the groups. Platelet counts were significantly lower in women with severe preeclampsia, compared to controls and women with chronic hypertension. Conclusion(s): Serum uric acid levels and plasma protein S activity may be useful as indices of severity of pathology in pregnancy associated hypertension. (c) 2005 Elsevier Ireland Ltd. All rights reserved.en10.1016/j.ejogrb.2005.03.020info:eu-repo/semantics/closedAccessPregnancyHypertensionPreeclampsiaCoagulation InhibitorsTurkish PopulationActivated Protein-CFactor-V-LeidenTumor-Necrosis-FactorInherited ThrombophiliaSevere PreeclampsiaResistanceMarkersDisordersMutationWomenConference Object1232183187N/AWOS:0002341019000092-s2.0-2844446290615893867N/A